Delivery Order W81K0421D0010-W81K0022F0127
- Not listed
- The Defense Health Agency awarded Hologic Sales and Service, LLC a $730.6K purchase order on October 1, 2023, for a Hologic Panther Analyzer nucleic acid amplification testing platform and associated reagents to support diagnostic testing at Brooke Army Medical Center in Fort Sam Houston, Texas. The contract, which operates under firm fixed-price terms with no small business set-aside, extends through May 31, 2025. The Panther Analyzer platform selected fulfills the Regional Health Contracting...
- Hologic Sales and Service, LLC, a division of Hologic, Inc., has been awarded a firm fixed-price delivery order against an existing indefinite-delivery/indefinite-quantity contract with the Defense Health Agency. The $543,750 task order is for the delivery of a molecular analyzer and reagents to support operations at Madigan Army Medical Center in Washington through September 2024. No set-aside designation was used for this award. Hologic will provide laboratory equipment, test kits, and related...
- Hologic Sales and Service, LLC was awarded a firm fixed price delivery order against an existing contract vehicle to provide SARS-CoV-2 assay kits to the Defense Health Agency. Valued at $704,626, this order was issued on October 1, 2022 to be completed by September 30, 2023. As the prime contractor, Hologic will deliver testing materials to support COVID-19 detection efforts at facilities located in Killeen, Texas. No set-aside provision was utilized for this award given Hologic's role as the...
- The Defense Health Agency awarded a delivery order valued at $29,860.50 to Hologic Sales And Service, LLC on July 21, 2025, for the procurement and delivery of COVID-19 testing supplies to Carl R. Darnall Army Medical Center (CRDAMC) at Fort Cavazos, Texas. The task order encompasses COVID-19 test kits, consumables, and controls for the Department of Microbiology Section, with an ultimate completion date of September 30, 2025. This delivery order was issued under a firm fixed-price contract type...
- Hologic Sales And Service, LLC, a subsidiary of Hologic, Inc., was awarded a $2.04 million firm fixed-price purchase order by the Defense Health Agency on March 1, 2022, to supply nucleic acid active reagents and assay kits for Panther and Fusion instruments at Tripler Army Medical Center. The contract, which runs through September 30, 2026, supports the medical diagnostic capabilities of the Defense Health Agency, which provides healthcare services to active-duty service members, military...
- The Defense Health Agency awarded a $80,485.50 firm fixed-price delivery order to Hologic Sales and Service, LLC on October 1, 2025, for the addition of COVID-19 testing capabilities to existing laboratory operations at Fort Cavazos, Texas. This task order, with a completion date of March 31, 2026, encompasses the provision of COVID-19 test kits, consumables, and controls required to support the military health system's diagnostic testing infrastructure. The award was made without a set-aside...
- The Defense Health Agency awarded a $62.3K firm fixed-price delivery order to Hologic Sales and Service, LLC on October 1, 2024, for Pather reagents supporting operations at Brooke Army Medical Center in Korea. The contract, which represents fiscal year 2025 first delivery order activity, carries an ultimate completion date of September 30, 2025, and was awarded without a set-aside designation. Performance will occur at the contractor's facility in Marlborough, Massachusetts. Hologic Sales and...
- Hologic, Inc. was awarded a $246,900 firm fixed price delivery order contract by the Defense Health Agency to provide COVID19 reagents. The contract supports the agency's response to the Coronavirus COVID-19 national emergency and has no set-aside designation. Under the terms of the award, Hologic will deliver test kit materials and supplies from its Marlborough, Massachusetts location to support the detection of SARS-CoV-2. No subcontractors were identified. The July 2, 2021 completion date...
- This federal contract award to Hologic Sales And Service, LLC, a subsidiary of Hologic, Inc., is for the provision of SARS-COV-2 assay kits. The $77,300 Firm Fixed Price Delivery Order was issued by the Defense Health Agency (DHA), a defense agency, and has a period of performance through September 30, 2025. The contract does not have a set-aside designation. In addition to this award, Hologic Sales And Service holds two larger indefinite-delivery/indefinite-quantity (IDIQ) contracts with the...
- This firm fixed-price purchase order, awarded to Hologic, Inc. by the Department of the Army Medical Command, provides INFECTIOUS DISEASES TESTING REAGENTS with a potential value of $249,000.00. The contract has a completion date of December 31, 2020 and was awarded on August 1, 2020 without the use of a set-aside. The contract requires Hologic to provide a range of reagents, test kits, controls, and consumables to enable molecular diagnostic testing on its proprietary Panther instrumentation...
- W81K0421D0010Indefinite Delivery Contract
- W81K0421D0010-W81K0022F0127Delivery Order
The Department of the Army Medical Command has awarded a $1,332,810 firm fixed price delivery order to Hologic Sales and Service, LLC for COVID reagents to be delivered to Brooke Army Medical Center in San Antonio, Texas by September 30, 2023. As the original equipment manufacturer, Hologic will supply proprietary reagents, test kits, controls and other consumables needed to enable COVID-19 molecular diagnostic testing on its Panther instrumentation installed at Brooke Army Medical Center. No set-aside designation was used for this sole source award given Hologic's unique position as the developer and supplier of these specialized products. Hologic Sales and Service is a division of Hologic, Inc., a leading provider of medical technology including diagnostic instruments, assays and related supplies to the Department of Defense and Department of Veterans Affairs.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Notice of Intent to Sole Source Gen-Probe - Fusion SARS-CoV-2 | W81K04-21-R-0018 | Department of the Army Medical Command | Special Notice 1/1 | 4/19/21, 5:40 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($2m) | 4/28/23 | |
| P00001 | Funding Only Action | $3.2m | 11/7/22 | |
| Not listed | Not listed | $0 | 9/8/22 |